Target intelligence / Profile preview

Deoxycytidylate deaminase (dCMP deaminase)

Target
dCMP deaminase
Molecular classification
Enzyme, Zinc-dependent cytidine deaminase family, Pyrimidine metabolism enzyme
01

Overview

Deoxycytidylate deaminase is a zinc-dependent enzyme involved in pyrimidine metabolism, specifically catalyzing the hydrolytic deamination of deoxycytidine-5'-monophosphate (dCMP) to deoxyuridine-5'-monophosphate (dUMP), which is an essential precursor for thymidylate synthase and DNA synthesis. It is a homohexamer allosterically regulated by dCTP (activator) and dTTP (inhibitor), modulating its activity to maintain balanced nucleotide pools for DNA replication and repair. The enzyme is predominantly found in rapidly dividing cells and has structural similarities with cytidine deaminase, possessing a conserved zinc-binding motif essential for its catalytic function. Its significance in cell proliferation and DNA synthesis makes it relevant as a potential therapeutic target, particularly in cancer chemotherapy where enzymes of nucleotide metabolism are frequently inhibited.

Other names
dCMP deaminaseDCMP deaminaseCytidine-5'-monophosphate deaminaseDeoxycytidine 5'-monophosphate deaminase
02

Mechanism of action

Drugs may inhibit or modulate dCMP deaminase to affect DNA synthesis or induce cytotoxicity in rapidly dividing cells (anticancer mechanism) Anti-metabolite drugs block pyrimidine synthesis via deamination modulation

03

Biological functions

Catalyzes the deamination of deoxycytidine-5'-monophosphate (dCMP) to deoxyuridine-5'-monophosphate (dUMP)Provides principal substrate for thymidylate synthase, facilitating DNA synthesisRegulates deoxynucleotide poolsParticipates in cellular pyrimidine metabolism
04

Disease associations

Cancer (as part of nucleotide metabolism and DNA synthesis, implicated in cell proliferation and targeted in chemotherapy)Other roles not well-established; dysregulation may affect DNA synthesis
05

Safety considerations

Disrupting dCMP deaminase activity can impair DNA synthesis, potentially causing cytotoxicity and off-target effects in non-tumor cell proliferationTherapeutic inhibition may lead to dose-limiting toxicities due to disruption of nucleotide metabolism
06

Interacting drugs

Pyrimidine analogs (e.g., anti-HIV and anti-hepatitis B drugs)

2 more in the full profile.

07

Biomarkers

Activity levels of deoxycytidylate deaminase may be monitored in hematological malignanciesIncreased enzyme activity can indicate proliferation or disease state

Beyond the preview

Go deeper on Deoxycytidylate deaminase (dCMP deaminase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deoxycytidylate deaminase (dCMP deaminase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call